Ranirestat
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Ranirestat, covering 2019-02-21 to 2019-02-21. Get the full timeline:
Most recent: Clinical Trial Update: Evaluating the Efficacy and Safety of Oral Ranirestat (40 and 80 mg) in Mild to Moderate Diabetic Sensorimotor Polyneuropathy [Phase 2, Phase 3]